메디채널

공유하기

Innovent Announces First Participant Dosed in a Phase 1 Clinical Trial of IBI3011, a Recombinant Anti-Human Interleukin 1 Receptor Accessory Protein Monoclonal Antibody

2025.12.10 08:26:00

많이 본 기사

더보기

섹션별 최근기사
섹션별 인기기사

경제IMG 작센안할트: 2026년 정조준 - 미래 산업을 향해 속도 내는 작센안할트주
엔터TORRAS Teams up With Artist GAWX to Launch "Guardian of Your Creativity" Collection Worldwide
라이프Alphamab Oncology Announces Biparatopic HER2-targeting ADC JSKN003 Was Granted Breakthrough Therapy Designation by the FDA for the Treatment of PROC
스포츠Abu Dhabi to Host 2026 Gran Turismo World Series Opener for the First Time in the Middle East
정치GIBO Announces Strategic Collaboration with Japan Benling Zhushi Clubs Limited to Develop AI-Powered Manned eVTOL Aircraft for Disaster Response and Geological Exploration
사회Miral Impact Fund Launched in Partnership with the Authority of Social Contribution - Ma'an to Champion Environmental Stewardship and Social Impact

발행인 : 최희정 | 편집인 : 김갑성 | 등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 | 주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동) Copyright @메디채널 Corp. All rights reserved.